Meade Castleton Edmunds IV

Meade Edmunds practices at Tennessee Ear, Nose & Throat Consultants in Knoxville, Tennessee.

Meade Edmunds' NPI, 1821595604, was assigned on April 9, 2018. Meade Edmunds graduated from Wake Forest University School of Medicine in 2018. Meade Edmunds holds Tennessee license 68494.

Meade Edmunds' primary practice is Tennessee Ear, Nose & Throat Consultants, at 501 20th St, Knoxville, TN 37916 in Knox County. The practice phone is (865) 693-6065.

Meade Edmunds' primary practice is Tennessee Ear, Nose & Throat Consultants in Knoxville, Tennessee. Meade Edmunds is also affiliated with The University of Tennessee Medical Center. The medical group on file is Ear, Nose & Throat Consultants of East Tennessee. Dmand AI also links Meade Edmunds to 3 more hospitals and 1 group practice or clinic, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Meade Edmunds practices, 5 sites in all. Vendor and product names are available with a free account.

Otolaryngology is Meade Edmunds' primary specialty in the NPI Registry, under taxonomy code 207Y00000X. Meade Edmunds is licensed in Tennessee.

CMS data shows 1,184 Medicare services from Meade Edmunds across 14 procedure codes in 2024, for 471 Medicare patients. Medicare paid $78,777 for them. Every service was in an office.

CMS counts 471 Medicare patients who saw Meade Edmunds in 2024. The largest group is 65 to 74, with 205 patients. 75% of them have high cholesterol, and 70% have high blood pressure. 5% are also on Medicaid. Their average risk score is 1.05, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Meade Edmunds' median patient age at 59, with 52% women.

In 2024, Meade Edmunds wrote 766 Medicare Part D claims for 323 patients. 98% of them were for generic drugs. CMS names the drug for 601 of them, across 11 drugs with 11 or more claims each, at $12,987 in total drug cost. In 2023, CMS named 117 claims across 6 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 75 out of 100 for Meade Edmunds for performance year 2024, reported as part of a group. Meade Edmunds accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS counts 31 procedures of melanoma (skin cancer) excision by Meade Edmunds, more than 80% of the clinicians it reports for that procedure.

Removal of tissue: 1 to 10 procedures (CMS shows small counts as a range)

CMS Open Payments shows 66 general payments to Meade Edmunds from 10 drug and device companies from 2023 to 2025. Food and beverage make up the largest share, 57% of the total. Inspire Medical Systems, Inc. paid the most, $1,790.

Meade Edmunds graduated from Wake Forest University School of Medicine in 2018.